AmerisourceBergen will be paying $815 million in cash for Springfield, Ill.-based H.D. Smith, which is currently the United States’ largest independent wholesaler.
The CVS Health Impact Dashboard is designed to show how the Woonsocket, R.I.-based company supports health care access in each state, officials said.
Drug Store News sat down with Chester “Chip” Davis, president and CEO of the Association for Accessible Medicines, to discuss how the generics industry is adapting to a changing market, and new opportunities manufacturers may be looking to pursue.
Patent expirations on branded drugs are the generics industry’s bread and butter — and the years to come hold a lot of promise.
Even as more approvals roll in and industry officials talk about how biosimilars will bring significant savings in the coming decade, there is a concern that regulatory and reimbursement hurdles could prevent the industry from realizing the full savings of the less-expensive alternative to biologics.
As the generics industry squares off against price deflation, manufacturers are looking for new product areas in need of lower-cost alternatives — and recent Food and Drug Administration efforts are helping with the discovery process.
Five companies are close to winning $75,000 from the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk.
The Merck Foundation has selected eight organizations that will implement programs to build partnerships between the healthcare sectors and others, redesign healthcare systems to improve diabetes care delivery and improve health outcomes for patients with diabetes.
The acquisition of LDI Integrated Pharmacy Services marks Diplomat’s second PBM acquisition this month, having acquired National Pharmaceutical Services on Nov. 6.
The findings suggest that clinicians should pay extra attention to females when conducting sleep-related assessments.